PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SPRO vs. TQQQ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between SPRO and TQQQ is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

SPRO vs. TQQQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Spero Therapeutics, Inc. (SPRO) and ProShares UltraPro QQQ (TQQQ). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%40.00%SeptemberOctoberNovemberDecember2025February
-32.51%
30.55%
SPRO
TQQQ

Key characteristics

Sharpe Ratio

SPRO:

-0.93

TQQQ:

0.94

Sortino Ratio

SPRO:

-1.48

TQQQ:

1.45

Omega Ratio

SPRO:

0.84

TQQQ:

1.19

Calmar Ratio

SPRO:

-0.47

TQQQ:

1.20

Martin Ratio

SPRO:

-1.57

TQQQ:

3.89

Ulcer Index

SPRO:

29.05%

TQQQ:

13.17%

Daily Std Dev

SPRO:

49.28%

TQQQ:

54.58%

Max Drawdown

SPRO:

-96.92%

TQQQ:

-81.66%

Current Drawdown

SPRO:

-96.30%

TQQQ:

-4.51%

Returns By Period

In the year-to-date period, SPRO achieves a -20.71% return, which is significantly lower than TQQQ's 12.21% return.


SPRO

YTD

-20.71%

1M

-16.17%

6M

-32.50%

1Y

-44.63%

5Y*

-38.20%

10Y*

N/A

TQQQ

YTD

12.21%

1M

17.20%

6M

30.55%

1Y

53.81%

5Y*

26.40%

10Y*

35.49%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SPRO vs. TQQQ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SPRO
The Risk-Adjusted Performance Rank of SPRO is 88
Overall Rank
The Sharpe Ratio Rank of SPRO is 55
Sharpe Ratio Rank
The Sortino Ratio Rank of SPRO is 55
Sortino Ratio Rank
The Omega Ratio Rank of SPRO is 88
Omega Ratio Rank
The Calmar Ratio Rank of SPRO is 1818
Calmar Ratio Rank
The Martin Ratio Rank of SPRO is 44
Martin Ratio Rank

TQQQ
The Risk-Adjusted Performance Rank of TQQQ is 4141
Overall Rank
The Sharpe Ratio Rank of TQQQ is 3737
Sharpe Ratio Rank
The Sortino Ratio Rank of TQQQ is 3939
Sortino Ratio Rank
The Omega Ratio Rank of TQQQ is 4141
Omega Ratio Rank
The Calmar Ratio Rank of TQQQ is 4747
Calmar Ratio Rank
The Martin Ratio Rank of TQQQ is 4141
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SPRO vs. TQQQ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Spero Therapeutics, Inc. (SPRO) and ProShares UltraPro QQQ (TQQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SPRO, currently valued at -0.93, compared to the broader market-2.000.002.004.00-0.930.94
The chart of Sortino ratio for SPRO, currently valued at -1.48, compared to the broader market-6.00-4.00-2.000.002.004.006.00-1.481.45
The chart of Omega ratio for SPRO, currently valued at 0.84, compared to the broader market0.501.001.502.000.841.19
The chart of Calmar ratio for SPRO, currently valued at -0.47, compared to the broader market0.002.004.006.00-0.471.20
The chart of Martin ratio for SPRO, currently valued at -1.57, compared to the broader market0.0010.0020.0030.00-1.573.89
SPRO
TQQQ

The current SPRO Sharpe Ratio is -0.93, which is lower than the TQQQ Sharpe Ratio of 0.94. The chart below compares the historical Sharpe Ratios of SPRO and TQQQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.93
0.94
SPRO
TQQQ

Dividends

SPRO vs. TQQQ - Dividend Comparison

SPRO has not paid dividends to shareholders, while TQQQ's dividend yield for the trailing twelve months is around 1.13%.


TTM20242023202220212020201920182017201620152014
SPRO
Spero Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TQQQ
ProShares UltraPro QQQ
1.13%1.27%1.26%0.57%0.00%0.00%0.06%0.11%0.00%0.00%0.01%0.03%

Drawdowns

SPRO vs. TQQQ - Drawdown Comparison

The maximum SPRO drawdown since its inception was -96.92%, which is greater than TQQQ's maximum drawdown of -81.66%. Use the drawdown chart below to compare losses from any high point for SPRO and TQQQ. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-96.30%
-4.51%
SPRO
TQQQ

Volatility

SPRO vs. TQQQ - Volatility Comparison

Spero Therapeutics, Inc. (SPRO) has a higher volatility of 24.34% compared to ProShares UltraPro QQQ (TQQQ) at 16.26%. This indicates that SPRO's price experiences larger fluctuations and is considered to be riskier than TQQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%SeptemberOctoberNovemberDecember2025February
24.34%
16.26%
SPRO
TQQQ
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab